BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 17277077)

  • 1. Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis.
    Urushitani M; Ezzi SA; Julien JP
    Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2495-500. PubMed ID: 17277077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS.
    Gros-Louis F; Soucy G; Larivière R; Julien JP
    J Neurochem; 2010 Jun; 113(5):1188-99. PubMed ID: 20345765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.
    Turner BJ; Talbot K
    Prog Neurobiol; 2008 May; 85(1):94-134. PubMed ID: 18282652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Amyotrophic lateral sclerosis: recent insights from transgenic animal models with SOD1 mutations].
    Aoki M
    Rinsho Shinkeigaku; 2004 Nov; 44(11):788-91. PubMed ID: 15651292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic immunization with a glatiramer acetate derivative does not alter survival in G93A and G37R SOD1 mouse models of familial ALS.
    Haenggeli C; Julien JP; Mosley RL; Perez N; Dhar A; Gendelman HE; Rothstein JD
    Neurobiol Dis; 2007 Apr; 26(1):146-52. PubMed ID: 17276077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit of tianeptine and morphine in a transgenic model of familial amyotrophic lateral sclerosis.
    Chritin M; Savasta M; Besson G
    Amyotroph Lateral Scler; 2006 Mar; 7(1):32-7. PubMed ID: 16546757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential for the use of mononuclear cells from human umbilical cord blood in the treatment of amyotrophic lateral sclerosis in SOD1 mice.
    Chen R; Ende N
    J Med; 2000; 31(1-2):21-30. PubMed ID: 10998753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for secretion of Cu,Zn superoxide dismutase via exosomes from a cell model of amyotrophic lateral sclerosis.
    Gomes C; Keller S; Altevogt P; Costa J
    Neurosci Lett; 2007 Nov; 428(1):43-6. PubMed ID: 17942226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Implications of successful immunotherapy in ALS model mice].
    Urushitani M
    Brain Nerve; 2008 Jun; 60(6):643-51. PubMed ID: 18567360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of protective immunity by vaccination with wild-type apo superoxide dismutase 1 in mutant SOD1 transgenic mice.
    Takeuchi S; Fujiwara N; Ido A; Oono M; Takeuchi Y; Tateno M; Suzuki K; Takahashi R; Tooyama I; Taniguchi N; Julien JP; Urushitani M
    J Neuropathol Exp Neurol; 2010 Oct; 69(10):1044-56. PubMed ID: 20838241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined immunosuppressive agents or CD4 antibodies prolong survival of human neural stem cell grafts and improve disease outcomes in amyotrophic lateral sclerosis transgenic mice.
    Yan J; Xu L; Welsh AM; Chen D; Hazel T; Johe K; Koliatsos VE
    Stem Cells; 2006 Aug; 24(8):1976-85. PubMed ID: 16644922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse effects of a SOD1-peptide immunotherapy on SOD1 G93A mouse slow model of amyotrophic lateral sclerosis.
    Sábado J; Casanovas A; Rodrigo H; Arqué G; Esquerda JE
    Neuroscience; 2015 Dec; 310():38-50. PubMed ID: 26384962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation of superoxide dismutase elevates reactive species: comparison of nitration and oxidation of proteins in different brain regions of transgenic mice with amyotrophic lateral sclerosis.
    Liu D; Bao F; Wen J; Liu J
    Neuroscience; 2007 Apr; 146(1):255-64. PubMed ID: 17368952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender difference in levels of Cu/Zn superoxide dismutase (SOD1) in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Frutiger K; Lukas TJ; Gorrie G; Ajroud-Driss S; Siddique T
    Amyotroph Lateral Scler; 2008 Jun; 9(3):184-7. PubMed ID: 18574763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of monomer/misfolded SOD1 as a therapeutic strategy for amyotrophic lateral sclerosis.
    Liu HN; Tjostheim S; Dasilva K; Taylor D; Zhao B; Rakhit R; Brown M; Chakrabartty A; McLaurin J; Robertson J
    J Neurosci; 2012 Jun; 32(26):8791-9. PubMed ID: 22745481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Animal models of amyotrophic lateral sclerosis].
    Yamanaka K
    Rinsho Shinkeigaku; 2007 Nov; 47(11):934-7. PubMed ID: 18210840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regular exercise is beneficial to a mouse model of amyotrophic lateral sclerosis.
    Kirkinezos IG; Hernandez D; Bradley WG; Moraes CT
    Ann Neurol; 2003 Jun; 53(6):804-7. PubMed ID: 12783429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adeno-associated virus-mediated delivery of a recombinant single-chain antibody against misfolded superoxide dismutase for treatment of amyotrophic lateral sclerosis.
    Patel P; Kriz J; Gravel M; Soucy G; Bareil C; Gravel C; Julien JP
    Mol Ther; 2014 Mar; 22(3):498-510. PubMed ID: 24394188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A human-derived antibody targets misfolded SOD1 and ameliorates motor symptoms in mouse models of amyotrophic lateral sclerosis.
    Maier M; Welt T; Wirth F; Montrasio F; Preisig D; McAfoose J; Vieira FG; Kulic L; Späni C; Stehle T; Perrin S; Weber M; Hock C; Nitsch RM; Grimm J
    Sci Transl Med; 2018 Dec; 10(470):. PubMed ID: 30518612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model.
    Ralph GS; Radcliffe PA; Day DM; Carthy JM; Leroux MA; Lee DC; Wong LF; Bilsland LG; Greensmith L; Kingsman SM; Mitrophanous KA; Mazarakis ND; Azzouz M
    Nat Med; 2005 Apr; 11(4):429-33. PubMed ID: 15768029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.